The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma

American Journal of Hematology

Volumn 88, Issue 12, 2013, Pages 997-1000

  O'Neill, Brian Patrick ^a,b   Decker, Paul A ^a,b   Tieu, Christina ^c   Cerhan, James R ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC CANCER CENTER   (United States)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Nothing to report

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HUMAN; KAPOSI SARCOMA; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; SEX DIFFERENCE; TREND STUDY; UNITED STATES;

NOTHING TO REPORT;

ADULT; AGE DISTRIBUTION; AGED; CENTRAL NERVOUS SYSTEM NEOPLASMS; FEMALE; HUMANS; INCIDENCE; LYMPHOMA, AIDS-RELATED; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MORBIDITY; REGISTRIES; SARCOMA, KAPOSI; SEER PROGRAM; SEX DISTRIBUTION; SKIN NEOPLASMS; UNITED STATES;

EID: 84888027733     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23551     Document Type: Article

References (11)

1. Villano JL, Koshy M, Shaikh H, et al. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma. Br J Cancer 2011;105:1414-1418.
2. Olson JE, Janney CA, Rao RD, et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer 2002;95:1504-1510.
3. Site Recode ICD-O-3 (1/27/2003) Definition. Available at: http://seer.cancer.gov/siterecode/icdo3_d01272003/.
4. Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006;107:265-276.
5. Uldrick TS, Whitby D. Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma. Cancer Lett 2011;305:150-162.
6. Haldorsen IS, Krakenes J, Goplen AK, et al. AIDS-related primary central nervous system lymphoma: A Norwegian national survey 1989-2003. BMC Cancer 2008;8:225.
7. Besson C, Goubar A, Gabarre J, et al. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 2001;98:2339-2344.
8. Wikby A, Maxson P, Olsson J, et al. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: The Swedish longitudinal OCTO-immune study. Mech Ageing Dev 1998;102:187-198.
9. Statistics Overview. Available at: http://www.cdc.gov/hiv/topics/surveillance/basic.htm.
10. Braggio E, McPhail ER, Macon W, et al. Primary central nervous system lymphomas: A validation study of array-based comparative genomic hybridization in formalin-fixed paraffin-embedded tumor specimens. Clin Cancer Res 2011;17:4245-4253.
11. Booman M, Szuhai K, Rosenwald A, et al. Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: The importance of apoptosis and immunomodulatory pathways. J Pathol 2008;216:209-217.